Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Chimeric Therapeutics Ltd. has announced the issuance of nearly 70 million fully paid ordinary shares for quotation on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, potentially attracting interest from investors tracking biotech stocks in the market.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.